miRNA signature associated with outcome of gastric cancer patients following chemotherapy

BACKGROUND: Identification of patients who likely will or will not benefit from cytotoxic chemotherapy through the use of biomarkers could greatly improve clinical management by better defining appropriate treatment options for patients. microRNAs may be potentially useful biomarkers that help guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Chang Hee, Kim, Hark K, Rettig, R Luke, Kim, Joseph, Lee, Eunbyul T, Aprelikova, Olga, Choi, Il J, Munroe, David J, Green, Jeffrey E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287139/
https://www.ncbi.nlm.nih.gov/pubmed/22112324
http://dx.doi.org/10.1186/1755-8794-4-79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287139/
https://www.ncbi.nlm.nih.gov/pubmed/22112324
http://dx.doi.org/10.1186/1755-8794-4-79

Ejemplares similares